Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
I've been pondering alternate risk-return tools lately, including the Ulcer Index and capture ratios. I was heartened to see that Ariel Global, whose manager is good and utterly adamant about the "the market on opioids" thing, was pretty consistently living up to her aspirations.
We'll profile LCORX in June. I needed to get Leuthold to answer a couple technical questions about strategy capacity and such, and couldn't get the final answer in time for this month's issue.
MFO Premium has been instrumental for us for our portfolio construction and risk management. Ulcer index and consistency are some of the key parameters we look for, especially in uncertain times like today. Ariel Global is a solid choice going into this turbulent time.
Comments
I've been pondering alternate risk-return tools lately, including the Ulcer Index and capture ratios. I was heartened to see that Ariel Global, whose manager is good and utterly adamant about the "the market on opioids" thing, was pretty consistently living up to her aspirations.
We'll profile LCORX in June. I needed to get Leuthold to answer a couple technical questions about strategy capacity and such, and couldn't get the final answer in time for this month's issue.
For what that's worth,
David